Sign in

Michael King

@profmikeking.bsky.social
97 followers 103 following 42 posts

President of AIMBE. E.D. Butcher Professor of Bioengineering at Rice University. Associate Vice President for Research. Special Advisor to the Provost. Okinawan-American. “…one of the novelists of our time…”

PostsRepliesMedia
Reposted by Michael King
Science X / Phys.org @sciencex.bsky.social · 24/07/2026
After six months of repeated shear stress, prostate cancer cells were induced to survive circulation-like force. CALB2 rose in those cells, but it does not appear to explain all of the resistance. doi.org/hccg9f
medicalxpress.com
New mechanoresistant cancer cells show how they survive high stress environments
When a cancer cell leaves the original tumor to spread to a new, faraway location, it first has to survive what most cells cannot: periodic high-force moments in the vessels and heart of up to 5,000 dynes per centimeter squared as it circulates throughout the body.
031
Michael King @profmikeking.bsky.social · 22/07/2026
New mechanoresistant cancer cells show how they survive high stress environments Rice research team develops cancer cell lines resistant to shear force news.rice.edu/news/2026/ne... advanced.onlinelibrary.wiley.com/doi/10.1002/...
news.rice.edu
010
Michael King @profmikeking.bsky.social · 08/07/2026
First time I’ve ever published a paper (preprint) in 8 different languages! Turns out that non-English prompts are a cheap and easy way to generate reference and hypothesis diversity in AI scientific ideation… engrxiv.org/preprint/vie...
000
Michael King @profmikeking.bsky.social · 01/07/2026
Submit a comment using this link to the comment builder tool: takeaction.aps.org/lp/n301wnzw #AIMBE, #OMBrule, #StandUpforScience @aimbe-official.bsky.social
010
Michael King @profmikeking.bsky.social · 08/05/2026
I am excited to give a webinar next week on the topic of “AI in Science and Research,” sponsored by the Controlled Release Society and organized by their Women in Science committee! Thank you Chiara Mancino for the invitation!
000
Michael King @profmikeking.bsky.social · 30/04/2026
I’m excited to be a Keynote Speaker at next Monday’s Lehigh Materials Symposium! Looking forward to seeing old friends and making new ones.
010
Michael King @profmikeking.bsky.social · 29/04/2026
Drs. Mike King (AIMBE President), Lola Eniola-Adefeso (AIMBE Immediate Past-President), and Dawn Beraud (AIMBE Executive Director) met with staff representatives from the BIOTech Caucus, as well as majority staff from the Senate Appropriations Committee… @aimbe-official.bsky.social
152
Reposted by Michael King
American Institute for Medical & Biological Engineering (AIMBE) @aimbe-official.bsky.social · 10/04/2026
🌸 🏛️ AIMBE is excited to host our largest-ever Capitol Hill Day on Monday, April 13. Ahead of meetings with Members of Congress and their staff, our 130+ Fellows, Emerging Leaders, and Council Representative will convene for an advocacy breakfast. #AIMBE2026
Logo of Boston University.Group photo of AIMBE's 2025 Advocacy Training.
153
Reposted by Michael King
American Institute for Medical & Biological Engineering (AIMBE) @aimbe-official.bsky.social · 10/04/2026
📜 View AIMBE’s congressional talking points here: aimbe.org/wp-content/u... Thank you to the @bostonu.bsky.social Department of Biomedical Engineering for graciously sponsoring this event. #AIMBE2026
lnkd.in
LinkedIn
This link will take you to a page that’s not on LinkedIn
022
Michael King @profmikeking.bsky.social · 10/04/2026
Protect U.S. Scientific Leadership and Reject FY2027 Proposed Cuts www.congressweb.com/AIMBE/12?fra... @aimbe-official.bsky.social
congressweb.com
Protect U.S. Scientific Leadership and Reject FY2027 Proposed Cuts
Use AIMBE's letter template below, edit as needed, or create your own message to your Members of Congress on issues that matter. Enter your contact information on the left, and your letter will be routed to your lawmakers. Please note: If your email is longer than 2,000 characters, it may be blocked.
032
Reposted by Michael King
American Institute for Medical & Biological Engineering (AIMBE) @aimbe-official.bsky.social · 10/04/2026
🚨✍️ AIMBE urges the scientific community to take a minute to send our new congressional letter opposing the President’s FY2027 budget proposal: bit.ly/420ig1A These proposed cuts to our scientific enterprise (e.g., NIH & NSF) would jeopardize training, research, and innovation driving our economy.
A screen capture of AIMBE's congressional letter campaign "Protect U.S. Scientific Leadership and Reject FY2027 Proposed Cuts."
1109
Reposted by Michael King
American Institute for Medical & Biological Engineering (AIMBE) @aimbe-official.bsky.social · 10/04/2026
On Monday, AIMBE will host its largest Capitol Hill Day with >130 Fellows and advocates meeting with Members of Congress and their staff to deliver this message in person. It's essential that lawmakers also hear directly from their constituents and the broader scientific community. #AIMBE2026
122
Reposted by Michael King
American Institute for Medical & Biological Engineering (AIMBE) @aimbe-official.bsky.social · 06/04/2026
Thank you to the Rice University School of Engineering and Computing and Rice University Department of Bioengineering for graciously sponsoring this event. #AIMBE2026 @profmikeking.bsky.social
022
Reposted by Michael King
American Institute for Medical & Biological Engineering (AIMBE) @aimbe-official.bsky.social · 06/04/2026
🎖️ Our awards banquet hosted by AIMBE Fellow Dr. Walter Baxter will take place during our Annual Event on April 12. We will announce the recipients of the Pierre Galletti Award, AIMBE's highest honor bestowed on an individual, and our Professional Impact Awards. Join us for a celebratory evening! 🎉
Logo for the Rice School of Engineering and Computing and Rice Department of Bioengineering.A group photo of the 2025 AIMBE Annual Event Awards Banquet recognizing all award recipients.
122
Reposted by Michael King
Science X / Phys.org @sciencex.bsky.social · 26/03/2026
A new 3D-printed platform enables efficient generation of cancer cell clusters, providing a more accurate model for studying the mechanisms behind cancer metastasis. doi.org/hbtznh
medicalxpress.com
3D-printed ATLAS platform helps model cancer cell clusters behind metastasis
Metastasis, the spread of cancer from a primary tumor to other parts of the body, is difficult to study in the lab, in part because researchers lack reliable ways to recreate the conditions cancer cells encounter as they travel through the bloodstream.
041
Michael King @profmikeking.bsky.social · 26/03/2026
Great news story about our new paper in Advanced Healthcare Materials, about a new cell culture system for studying metaststic cancer… congrats to Alex Carter and team!! #OpenAccess news.rice.edu/news/2026/sc... t.co/ODQTaku8WM
000
Michael King @profmikeking.bsky.social · 25/03/2026
act.fightcancer.org/a/tx-cprit-p... @aimbe-official.bsky.social @americancancersoc.bsky.social
012
Michael King @profmikeking.bsky.social · 12/03/2026
🚨new GBM paper alert!🚨 What if I told you… that there was a safe, approved, BBB-accessible drug that can prime glioblastoma cells for apoptosis? #OpenAccess Fun fact: co-1st author Shanay Desai was a King Lab undergrad, now in grad studies at Penn! doi.org/10.1021/acso...
000
Reposted by Michael King
Liz Wayne @lizwaynephd.bsky.social · 26/02/2026
This was a super fun and insightful conversation! Thanks for joining the podcast Mike! @profmikeking.bsky.social I forgot to bring to ask you about your book!
142
Michael King @profmikeking.bsky.social · 24/02/2026
Wake up babe, new BMES podcast just dropped! Had a great time talking about the value of professional societies with my friend @lizwaynephd.bsky.social … Liz is the best in the biz and I was honored to share my experiences with BMES… give it a listen! 🎧🎙️🗣️ www.bmes.org/podcast/offi...
043
Reposted by Michael King
American Institute for Medical & Biological Engineering (AIMBE) @aimbe-official.bsky.social · 17/02/2026
SBIR and STTR programs lapsed on Oct. 1, 2025, halting new solicitations across federal agencies, including NIH and NSF. Delays to their restoration will disrupt the commercialization of technologies that are foundational to America's leadership in STEM innovation and economic competitiveness.
173
Reposted by Michael King
American Institute for Medical & Biological Engineering (AIMBE) @aimbe-official.bsky.social · 17/02/2026
🚨 AIMBE calls on the scientific community to take a minute to send our new advocacy letter urging Congress to support the immediate reauthorization of Small Business Innovation Research (SBIR) & Small Business Technology Transfer (STTR) programs! Please share 👇 takeaction.io/aimbe/sbir-s...
takeaction.io
SBIR/STTR Reauthorization Urgently Needed
Use AIMBE's letter template below to send an email to your Members of Congress on issues that matter. We encourage you to edit and personalize the note, sharing your individual experience. Please note...
1116
Michael King @profmikeking.bsky.social · 12/02/2026
As a Guest Editor for JoVE, I am organizing a Topical Collection titled “Techniques for the Control of Immune Cell Function Using Physical Forces.” Interested in contributing? Please submit an abstract here: app.jove.com/methods-coll...
000
Reposted by Michael King
Inside Higher Ed @insidehighered.com · 30/01/2026
Opinion | ‘Extraordinary and Unconstitutional’ Indeed The University of Pennsylvania is right to resist the Trump administration’s demand for lists of Jewish employees. bit.ly/3MhKEIl
A photo of a University of Pennsylvania campus building with snow on the ground in front of it.
092
Reposted by Michael King
Science X / Phys.org @sciencex.bsky.social · 21/02/2025
Combining tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) with focused ultrasound significantly reduces tumor size in prostate cancer models, offering a promising noninvasive treatment approach. doi.org/g85s2v
medicalxpress.com
Combining protein therapy and focused ultrasound therapy can improve cancer treatment
Combining an existing small-molecule protein therapy called tumor necrosis factor related apoptosis-inducing ligand (TRAIL) with focused ultrasound (FUS) can significantly reduce tumor size and burden in prostate cancer models, according to a new study published in Advanced Science by researchers at Rice University and Vanderbilt University.
111
Michael King @profmikeking.bsky.social · 22/01/2026
¿Qué pasa? 🚨new paper alert!🚨 I am excited to share our new paper, an important collaboration with Dr. Cathy Eng and VUMC: Increased prolactin levels in pregnancy affect colorectal cancer aggressiveness #OpenAccess 🧵👇 link.springer.com/article/10.1...
111
Reposted by Michael King
bioRxivpreprint @biorxivpreprint.bsky.social · 30/12/2025
Pipette, mix, repeat: A reduced-order fluid model and protocol survey to evaluate 96-well mixing protocols www.biorxiv.org/content/10.64898/20…
042
Reposted by Michael King
American Institute for Medical & Biological Engineering (AIMBE) @aimbe-official.bsky.social · 18/11/2025
AIMBE has been busy with conferences this month! Last week, @dawnberaud.bsky.social hosted a session titled "The Importance of Advocacy in BME Research" @termisam.bsky.social which featured talks from AIMBE Fellows @cosgriffhernandez.bsky.social, @profharley.bsky.social, and Dr. Joyce Wong. (1/4)
A group photo of Drs. Elizabeth Cosgriff-Hernandez, Brendan Harley, Joyce Wong, and Dawn Beraud during AIMBE's advocacy session at the 2025 TERMIS-AM Meeting in Detroit, Michigan.
143
Reposted by Michael King
American Institute for Medical & Biological Engineering (AIMBE) @aimbe-official.bsky.social · 18/11/2025
Yesterday, Drs. Beraud and Marvin and Sarah organized a networking event during the @amsocmatbio.bsky.social Meeting in Baltimore. We were delighted to connect with nearly 20 AIMBE Fellows, Emerging Leaders, and Council Representatives over an evening of food and conversation 🍤 (2/4)
AIMBE staff, Sarah Mandell (left), Dr. Jason Marvin (second from left), Dr. Dawn Beraud (second from right), and AIMBE Fellow Dr. Mete Civelek (right). They are at AIMBE's networking event held at the 2025 American Society for Matrix Biology (ASMB) Meeting in Baltimore, Maryland.
142
Reposted by Michael King
American Institute for Medical & Biological Engineering (AIMBE) @aimbe-official.bsky.social · 04/11/2025
AIMBE is hosting a breakfast roundtable titled "The Importance of Advocacy in Biomedical Engineering and Medical Research" at the @amsocmatbio.bsky.social Meeting on 11/18! Join @dawnberaud.bsky.social, @jasoncmarvin.bsky.social, and our AIMBE members for this important conversation on advocacy 👇
A flyer for AIMBE's advocacy breakfast roundtable titled "The Importance of Advocacy in Biomedical Engineering and Medical Research" at the 2025 American Society for Matrix Biology (ASMB) Biennial Meeting on Tuesday, November 18th from 7:15-8:30 AM in Baltimore, Maryland.
263
Reposted by Michael King
Nature Reviews Psychology @natrevpsychol.nature.com · 08/10/2025
Nature Reviews Psychology is encouraging authors to include a citation diversity statement to draw attention to citation imbalances and confirm that they made efforts to cite publications from a diverse group of researchers. Read more in our editorial: go.nature.com/4mTIpr2
0205
Michael King @profmikeking.bsky.social · 07/10/2025
It’s finally BMES week! The King Lab is giving 6 oral and 12 poster presentations, with a delegation that includes high school student, undergrad, PhD students, postdocs, research professor and… moi! Check out our work, and also visit the Rice BIOE booth and reception!
040
Michael King @profmikeking.bsky.social · 26/09/2025
The new restriction by the NSF, barring 2nd year PhD students from applying for the GRFP, is deeply unfair and ill-timed. My colleague Cindy Reinhart-King weighs in on the news in an AAAS Science article posted today (free access): 👇 www.science.org/content/arti...
science.org
‘Completely shattered.’ Changes to NSF’s graduate student fellowship spur outcry
The announcement comes months later than usual, leaving many would-be applicants stranded
020
Reposted by Michael King
American Institute for Medical & Biological Engineering (AIMBE) @aimbe-official.bsky.social · 23/09/2025
🚨 AIMBE calls on the scientific community to urge Congress to ensure timely passage of the FY2026 budget 👇 Strong, sustained funding for our nation's health and science agencies is essential for economic prosperity, U.S. global competitiveness, and public heath. takeaction.io/aimbe/protec...
takeaction.io
Protect Research: Finalize FY2026 Budget Now
Use AIMBE's letter template below to send an email to your Members of Congress on issues that matter. We encourage you to edit and personalize the note, sharing your individual experience. Please note...
22317
Michael King @profmikeking.bsky.social · 23/09/2025
Protect Research: Finalize FY2026 Budget Now www.congressweb.com/AIMBE/10?fra...
congressweb.com
Protect Research: Finalize FY2026 Budget Now
Use AIMBE's letter template below to send an email to your Members of Congress on issues that matter. We encourage you to edit and personalize the note, sharing your individual experience. Please note...
021
Michael King @profmikeking.bsky.social · 19/09/2025
🚨 NEW PAPER ALERT! 🚨 Our new review on “Cellular mechanoactivation of antigen-presenting cells and T cells for cancer immunotherapy” in Current Opinion in Biomedical Engineering! Free #OpenAccess download for all readers! #immunoengineering #mechanobiology www.sciencedirect.com/science/arti...
030
Michael King @profmikeking.bsky.social · 16/09/2025
Amazing! Friend and fellow mechanobiologist Nadeen Chahine was in San Diego and caught a Padres game… and it was Michael King bobblehead night! Thank you so much Nadeen, this is going to look great in my office! 👑⚾️
021
Michael King @profmikeking.bsky.social · 26/08/2025
news.rice.edu/news/2025/st...
news.rice.edu
000
Michael King @profmikeking.bsky.social · 26/08/2025
I made a blog post (“Analyzing Diversity”) on the @springernature.com Communities platform about our new paper in @natmachintell.nature.com ! @natureportfolio.nature.com go.nature.com/4fUysaY
go.nature.com
Analyzing Diversity: Citation Diversity Reports made easy
In this behind-the-paper blog post, I provide background and context on our recent publication in Nature Machine Intelligence, that reports on the ability of large language models to generate publicat...
051
Michael King @profmikeking.bsky.social · 25/08/2025
🚨 new paper alert! 🚨 Excited to share our latest paper in @natmachintell.nature.com , we tested 27 large language models to see if any could generate a publication-ready Citation Diversity Report… and several (free) LLMs could! Read paper for free at link: rdcu.be/eCfwJ @natureportfolio.nature.com
rdcu.be
LLMs as all-in-one tools to easily generate publication-ready citation diversity reports
Nature Machine Intelligence - LLMs as all-in-one tools to easily generate publication-ready citation diversity reports
011
Reposted by Michael King
Woojin Han @thewooj.bsky.social · 23/08/2025
This recognition is especially meaningful to me. As a PhD student and postdoc, I had the chance to work with former EIC Prof. Michael King as an assistant editor supporting this journal. Now, I am grateful to current EIC Prof. Ed Sander and the selection committee for this honor.
031
Reposted by Michael King
Woojin Han @thewooj.bsky.social · 23/08/2025
Our lab’s work is now published in Cellular and Molecular Bioengineering (CMBE) Journal, appearing in the 2025 Young Innovators Issue. I am excited to share it! link.springer.com/article/10.1...
link.springer.com
WNT7A mRNA Lipid Nanoparticles Promote Muscle Hypertrophy and Reduce Fatty Infiltration - Cellular and Molecular Bioengineering
Purpose Myosteatosis and muscle atrophy are key pathological features of skeletal muscle degeneration in chronic injuries, degenerative myopathies, and aging. While recombinant WNT7A has shown promise...
172
Reposted by Michael King
boehninglab @boehninglab.com · 08/07/2025
This is extraordinarily dangerous and will slow academic biomedical research and drug development. A total ban is on the horizon. www.drugdiscoverytrends.com/nih-announce...
drugdiscoverytrends.com
NIH announces end to funding for animal-only studies - Drug Discovery and Development
Drug Discovery and Development covers strategies and technologies related to pharmaceutical research and development and drug formulation.
1216981
Reposted by Michael King
Eliza Bliss-Moreau @eblissmoreau.bsky.social · 08/07/2025
The line between “no Medicaid for you” and “the only option for access to ‘health care’ if you don’t have insurance is participating in risky, untested interventions” is a short one. Animal models are the bridge from bench to bedside.
1499
Reposted by Michael King
Eliza Bliss-Moreau @eblissmoreau.bsky.social · 08/07/2025
Public comment on this new "no animal only studies" is open here: www.fda.gov/news-events/... It closes next Monday.
fda.gov
FDA-NIH Workshop: Reducing Animal Testing
The FDA is hosting a workshop on reducing animal testing. The workshop is open to current FDA and NIH employees.
11722
Reposted by Michael King
cmbejournal.bsky.social @cmbejournal.bsky.social · 24/06/2025
I'm pleased to announce that CMBE now has an impact factor of 5.0! And don't forget, there's no publishing fee.
021
Reposted by Michael King
American Institute for Medical & Biological Engineering (AIMBE) @aimbe-official.bsky.social · 20/06/2025
AIMBE has launched our new Citizen Advocate for Science Letter: takeaction.io/aimbe/scienc... We ask the broader scientific community to widely share this letter (✍️ <1 minute) with friends, family, and other concerned citizens to urge their elected officials to protect biomedical research funding 👇
aimbe.org
Write Your Lawmakers - AIMBE
12119
Michael King @profmikeking.bsky.social · 19/06/2025
I'm pleased to share this nicely done video that captures how special the Rice partnership with the Texas Medical Center is for biomedical researchers... 🔬 🧪 🏙️
020
Michael King @profmikeking.bsky.social · 14/05/2025
Check out this awesome recap story and video on our recent Health Innovations symposium… Thank you to everyone who helped to make this event a great success! @riceenrich.bsky.social news.rice.edu/news/2025/en...
news.rice.edu
110
Reposted by Michael King
American Institute for Medical & Biological Engineering (AIMBE) @aimbe-official.bsky.social · 04/02/2025
AIMBE has posted a public statement on the impact of federal policy changes on biomedical research: aimbe.org/advocate/wri... Above, we have also developed an advocacy letter for members of the medical & biological engineering community to send to their congressional representatives on this matter.
aimbe.org
Write Your Lawmakers - AIMBE
116767